- Home
- PED vs ACET Comparison
PED vs ACET Comparison
Compare PED & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- ACET
- Stock Information
- Founded
- PED N/A
- ACET 1947
- Country
- PED United States
- ACET United States
- Employees
- PED N/A
- ACET N/A
- Industry
- PED Oil & Gas Production
- ACET Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- ACET Health Care
- Exchange
- PED Nasdaq
- ACET Nasdaq
- Market Cap
- PED 48.8M
- ACET 44.4M
- IPO Year
- PED N/A
- ACET N/A
- Fundamental
- Price
- PED $0.56
- ACET $0.53
- Analyst Decision
- PED Strong Buy
- ACET Buy
- Analyst Count
- PED 3
- ACET 6
- Target Price
- PED $1.83
- ACET $6.00
- AVG Volume (30 Days)
- PED 174.7K
- ACET 597.2K
- Earning Date
- PED 05-14-2025
- ACET 05-13-2025
- Dividend Yield
- PED N/A
- ACET N/A
- EPS Growth
- PED 921.21
- ACET N/A
- EPS
- PED 0.20
- ACET N/A
- Revenue
- PED $39,553,000.00
- ACET N/A
- Revenue This Year
- PED $1.03
- ACET N/A
- Revenue Next Year
- PED $68.58
- ACET N/A
- P/E Ratio
- PED $2.81
- ACET N/A
- Revenue Growth
- PED 28.49
- ACET N/A
- 52 Week Low
- PED $0.47
- ACET $0.45
- 52 Week High
- PED $1.10
- ACET $2.29
- Technical
- Relative Strength Index (RSI)
- PED 35.50
- ACET 34.42
- Support Level
- PED $0.54
- ACET $0.45
- Resistance Level
- PED $0.58
- ACET $0.61
- Average True Range (ATR)
- PED 0.06
- ACET 0.07
- MACD
- PED -0.00
- ACET -0.01
- Stochastic Oscillator
- PED 34.09
- ACET 21.18
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.